Literature DB >> 12544072

Vascular responses in normal canine carotid arteries: comparison between various self-expanding stents of the same unconstrained size.

Sang-Hoon Cha1, Moon Hee Han, Young Ho Choi, Chang Jin Yoon, Seung Kug Baik, Sung Jin Kim, Kee-Hyun Chang.   

Abstract

RATIONALE AND
OBJECTIVES: To compare long-term vascular responses upon the insertion of various self-expandable stents, all the same unconstrained size, in canine carotid artery models.
MATERIALS AND METHODS: Twenty-two stents (5 SMARTs, 5 Wallstents, 6 Niti-Ss, 6 Niti-Ds) of the same unconstrained size (6 mm in diameter, 20 mm in length) were endovascularly placed in canine common carotid arteries. The luminal changes were measured on three occasions, on prestenting, immediate poststenting, and angiograms taken before specimens were killed. After en-bloc harvest of the stented carotid arteries at 6 months, the intraluminal surface was evaluated by gross observation and scanning electron microscopy (SEM). Neointimal thickness was measured at several points both over the wire and between the wires.
RESULTS: Niti-D was excluded from analysis because of high rate of poststenting occlusion. SMART stent showed the greatest expansibility with average initial luminal gain ( < 0.05) of 21.2% (Niti-S: 16.5%, Wallstent: 12.9%). At 6 months follow-up, the dilated arterial lumen had returned almost to the prestenting caliber without any significant differences among the stent types ( > 0.05). The thickness of neointimal coverage was more prominent with SMART stent (354 microm over the wire and 258 microm between the wires) than Niti-S (228 microm and 83 microm) or Wallstent (187 microm and 78 microm).
CONCLUSION: Stent types with its higher initial luminal gain appeared to be associated with thicker neointimal formation at 6 months. The acute expanding force of a self-expanding stent may be the key to the cause of neointimal hyperplasia. Regardless of the inserted stent type, the variations in neointimal response were offset by luminal gains of varying degree, thus preserving the arterial patency almost to the prestenting size.

Entities:  

Mesh:

Year:  2003        PMID: 12544072     DOI: 10.1097/01.RLI.0000044932.99555.E1

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  5 in total

1.  Neointimal hyperplasia after stent placement across size-discrepant vessels in an animal study.

Authors:  Hisayuki Cho; Mineyoshi Nango; Yukimasa Sakai; Etsuji Sohgawa; Ken Kageyama; Shinichi Hamamoto; Toshiaki Kitayama; Akira Yamamoto; Yukio Miki
Journal:  Jpn J Radiol       Date:  2014-04-09       Impact factor: 2.374

2.  Large animals in neurointerventional research: A systematic review on models, techniques and their application in endovascular procedures for stroke, aneurysms and vascular malformations.

Authors:  Andrea M Herrmann; Stephan Meckel; Matthew J Gounis; Leona Kringe; Edith Motschall; Christoph Mülling; Johannes Boltze
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-07       Impact factor: 6.200

3.  Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study.

Authors:  Marianne Brodmann; Christian Wissgott; Andrew Holden; Robert Staffa; Thomas Zeller; Thodur Vasudevan; Peter Schneider
Journal:  Catheter Cardiovasc Interv       Date:  2018-03-24       Impact factor: 2.692

4.  Effect of Stent Radial Force on Stress Pattern After Deployment: A Finite Element Study.

Authors:  Alessandro Borghi; Olive Murphy; Reza Bahmanyar; Chris McLeod
Journal:  J Mater Eng Perform       Date:  2014-02-26       Impact factor: 1.819

5.  Impact of chronic outward force on arterial responses of proximal and distal of long superficial femoral artery stent.

Authors:  Hu Li; Seung-Woon Rha; Byoung Geol Choi; Se Yeon Choi; Sang Ki Moon; Won Young Jang; Woohyeun Kim; Ji Hun Ahn; Sang-Ho Park; Woong Gil Choi; Rui Feng Yang; Wen Wei Bai; Cheol Ung Choi; Yang Gi Ryu; Man Jong Baek; Dong Joo Oh
Journal:  BMC Cardiovasc Disord       Date:  2021-06-30       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.